Bortezomib for antibody mediated rejection treatment: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City.

Clinical transplants

Volumn , Issue , 2009, Pages 369-376

  Leyva, Sergio ^a   Marino Vázquez, Lluvia A ^b   Reyes Loaeza, Jorge A ^b   Vega, Olynka ^b   Uribe Uribe, Norma ^b   Alberú, Josefina ^b   Morales Buenrostro, Luis E ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BORONIC ACID DERIVATIVE; BORTEZOMIB; CREATININE; HLA ANTIGEN; PROTEINASE INHIBITOR; PYRAZINE DERIVATIVE;

ADULT; ARTICLE; BIOPSY; BLOOD; CADAVER; DONOR; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOLOGY; LIVING DONOR; MALE; MEXICO; PATHOLOGY; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; BIOPSY; BORONIC ACIDS; CADAVER; CREATININE; FEMALE; GRAFT REJECTION; HLA ANTIGENS; HUMANS; LIVING DONORS; MALE; MEXICO; PROTEASE INHIBITORS; PYRAZINES; T-LYMPHOCYTES; TISSUE DONORS; TREATMENT OUTCOME;

EID: 77954601189     PISSN: 08909016     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)